Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

To use or not to use corticosteroids for pneumonia? A clinician's perspective.

Identifieur interne : 001282 ( Main/Exploration ); précédent : 001281; suivant : 001283

To use or not to use corticosteroids for pneumonia? A clinician's perspective.

Auteurs : M. Confalonieri [Italie] ; M. Kodric ; M. Santagiuliana ; C. Longo ; M. Biolo ; R. Cifaldi ; C. Torregiani ; M. Jevnikar

Source :

RBID : pubmed:23193846

Descripteurs français

English descriptors

Abstract

The use of corticosteroids in the management of pneumonia is still a controversial issue. The physicians in daily clinical practice often use corticosteroids in patients with pneumonia for different reasons all over the world. As an example of real life is the frequent use of corticosteroids to treat patients with pneumonia due to H1N1 pandemic influenza in spite of WHO' statements that clearly discouraged this therapy. In fact, the literature up to august 2012 reported a total of 6,650 patients with pneumonia due to H1N1 virus infection (of whom 2,515 were ICU patients): corticosteroids were used with various dose regimen in 2404 patients (37.8%). The attitude of international guidelines on pneumonia in using steroids do not help the clinician to clearly choice when and how to treat pneumonia with steroids. However, stress doses of corticosteroids are suggested by some major guidelines on community-acquired pneumonia in case of severe episodes with sepsis. To date, there are 10 randomised controlled trials assessing the effectiveness of corticosteroids for community-acquired pneumonia globally involving 1090 participants. Most of the trials adopted stress doses of glucorticoids for 4-7 days. The evidence from these trials taken separately is weak due to limitations of the studies themselves, but a Cochrane review and a systematic review found benefit using prolonged low doses of glucocorticoids in severe community-acquired pneumonia. Moreover, such a strategy decreases vasopressor dependency and appears to be safe. Nevertheless, larger trials with more patients and clinically important end-points were claimed to provide robust evidence. Finally, infection surveillance is critical in patients treated with corticosteroids, and to prevent the rebound phenomenon, the drug should be weaned slowly.

DOI: 10.4081/monaldi.2012.157
PubMed: 23193846


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">To use or not to use corticosteroids for pneumonia? A clinician's perspective.</title>
<author>
<name sortKey="Confalonieri, M" sort="Confalonieri, M" uniqKey="Confalonieri M" first="M" last="Confalonieri">M. Confalonieri</name>
<affiliation wicri:level="1">
<nlm:affiliation>Struttura Complessa Pneumologia, Azienda Ospedaliero-Universitaria "Ospedali Riuniti" di Trieste, Ospedale di Cattinara, Trieste, Italy. marco.confalonieri@aots.sanita.fvg.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Struttura Complessa Pneumologia, Azienda Ospedaliero-Universitaria "Ospedali Riuniti" di Trieste, Ospedale di Cattinara, Trieste</wicri:regionArea>
<wicri:noRegion>Trieste</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kodric, M" sort="Kodric, M" uniqKey="Kodric M" first="M" last="Kodric">M. Kodric</name>
</author>
<author>
<name sortKey="Santagiuliana, M" sort="Santagiuliana, M" uniqKey="Santagiuliana M" first="M" last="Santagiuliana">M. Santagiuliana</name>
</author>
<author>
<name sortKey="Longo, C" sort="Longo, C" uniqKey="Longo C" first="C" last="Longo">C. Longo</name>
</author>
<author>
<name sortKey="Biolo, M" sort="Biolo, M" uniqKey="Biolo M" first="M" last="Biolo">M. Biolo</name>
</author>
<author>
<name sortKey="Cifaldi, R" sort="Cifaldi, R" uniqKey="Cifaldi R" first="R" last="Cifaldi">R. Cifaldi</name>
</author>
<author>
<name sortKey="Torregiani, C" sort="Torregiani, C" uniqKey="Torregiani C" first="C" last="Torregiani">C. Torregiani</name>
</author>
<author>
<name sortKey="Jevnikar, M" sort="Jevnikar, M" uniqKey="Jevnikar M" first="M" last="Jevnikar">M. Jevnikar</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:23193846</idno>
<idno type="pmid">23193846</idno>
<idno type="doi">10.4081/monaldi.2012.157</idno>
<idno type="wicri:Area/PubMed/Corpus">000546</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000546</idno>
<idno type="wicri:Area/PubMed/Curation">000544</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000544</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000545</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000545</idno>
<idno type="wicri:Area/Ncbi/Merge">000552</idno>
<idno type="wicri:Area/Ncbi/Curation">000552</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000552</idno>
<idno type="wicri:doubleKey">1122-0643:2012:Confalonieri M:to:use:or</idno>
<idno type="wicri:Area/Main/Merge">001284</idno>
<idno type="wicri:Area/Main/Curation">001282</idno>
<idno type="wicri:Area/Main/Exploration">001282</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">To use or not to use corticosteroids for pneumonia? A clinician's perspective.</title>
<author>
<name sortKey="Confalonieri, M" sort="Confalonieri, M" uniqKey="Confalonieri M" first="M" last="Confalonieri">M. Confalonieri</name>
<affiliation wicri:level="1">
<nlm:affiliation>Struttura Complessa Pneumologia, Azienda Ospedaliero-Universitaria "Ospedali Riuniti" di Trieste, Ospedale di Cattinara, Trieste, Italy. marco.confalonieri@aots.sanita.fvg.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Struttura Complessa Pneumologia, Azienda Ospedaliero-Universitaria "Ospedali Riuniti" di Trieste, Ospedale di Cattinara, Trieste</wicri:regionArea>
<wicri:noRegion>Trieste</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kodric, M" sort="Kodric, M" uniqKey="Kodric M" first="M" last="Kodric">M. Kodric</name>
</author>
<author>
<name sortKey="Santagiuliana, M" sort="Santagiuliana, M" uniqKey="Santagiuliana M" first="M" last="Santagiuliana">M. Santagiuliana</name>
</author>
<author>
<name sortKey="Longo, C" sort="Longo, C" uniqKey="Longo C" first="C" last="Longo">C. Longo</name>
</author>
<author>
<name sortKey="Biolo, M" sort="Biolo, M" uniqKey="Biolo M" first="M" last="Biolo">M. Biolo</name>
</author>
<author>
<name sortKey="Cifaldi, R" sort="Cifaldi, R" uniqKey="Cifaldi R" first="R" last="Cifaldi">R. Cifaldi</name>
</author>
<author>
<name sortKey="Torregiani, C" sort="Torregiani, C" uniqKey="Torregiani C" first="C" last="Torregiani">C. Torregiani</name>
</author>
<author>
<name sortKey="Jevnikar, M" sort="Jevnikar, M" uniqKey="Jevnikar M" first="M" last="Jevnikar">M. Jevnikar</name>
</author>
</analytic>
<series>
<title level="j">Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace</title>
<idno type="ISSN">1122-0643</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Decision Making</term>
<term>Glucocorticoids (therapeutic use)</term>
<term>Humans</term>
<term>Pneumonia (drug therapy)</term>
<term>Practice Guidelines as Topic</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Glucocorticoïdes (usage thérapeutique)</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Pneumopathie infectieuse (traitement médicamenteux)</term>
<term>Prise de décision</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Glucocorticoids</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Pneumonia</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Pneumopathie infectieuse</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Glucocorticoïdes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Decision Making</term>
<term>Humans</term>
<term>Practice Guidelines as Topic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Prise de décision</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The use of corticosteroids in the management of pneumonia is still a controversial issue. The physicians in daily clinical practice often use corticosteroids in patients with pneumonia for different reasons all over the world. As an example of real life is the frequent use of corticosteroids to treat patients with pneumonia due to H1N1 pandemic influenza in spite of WHO' statements that clearly discouraged this therapy. In fact, the literature up to august 2012 reported a total of 6,650 patients with pneumonia due to H1N1 virus infection (of whom 2,515 were ICU patients): corticosteroids were used with various dose regimen in 2404 patients (37.8%). The attitude of international guidelines on pneumonia in using steroids do not help the clinician to clearly choice when and how to treat pneumonia with steroids. However, stress doses of corticosteroids are suggested by some major guidelines on community-acquired pneumonia in case of severe episodes with sepsis. To date, there are 10 randomised controlled trials assessing the effectiveness of corticosteroids for community-acquired pneumonia globally involving 1090 participants. Most of the trials adopted stress doses of glucorticoids for 4-7 days. The evidence from these trials taken separately is weak due to limitations of the studies themselves, but a Cochrane review and a systematic review found benefit using prolonged low doses of glucocorticoids in severe community-acquired pneumonia. Moreover, such a strategy decreases vasopressor dependency and appears to be safe. Nevertheless, larger trials with more patients and clinically important end-points were claimed to provide robust evidence. Finally, infection surveillance is critical in patients treated with corticosteroids, and to prevent the rebound phenomenon, the drug should be weaned slowly.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Italie</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Biolo, M" sort="Biolo, M" uniqKey="Biolo M" first="M" last="Biolo">M. Biolo</name>
<name sortKey="Cifaldi, R" sort="Cifaldi, R" uniqKey="Cifaldi R" first="R" last="Cifaldi">R. Cifaldi</name>
<name sortKey="Jevnikar, M" sort="Jevnikar, M" uniqKey="Jevnikar M" first="M" last="Jevnikar">M. Jevnikar</name>
<name sortKey="Kodric, M" sort="Kodric, M" uniqKey="Kodric M" first="M" last="Kodric">M. Kodric</name>
<name sortKey="Longo, C" sort="Longo, C" uniqKey="Longo C" first="C" last="Longo">C. Longo</name>
<name sortKey="Santagiuliana, M" sort="Santagiuliana, M" uniqKey="Santagiuliana M" first="M" last="Santagiuliana">M. Santagiuliana</name>
<name sortKey="Torregiani, C" sort="Torregiani, C" uniqKey="Torregiani C" first="C" last="Torregiani">C. Torregiani</name>
</noCountry>
<country name="Italie">
<noRegion>
<name sortKey="Confalonieri, M" sort="Confalonieri, M" uniqKey="Confalonieri M" first="M" last="Confalonieri">M. Confalonieri</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001282 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001282 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:23193846
   |texte=   To use or not to use corticosteroids for pneumonia? A clinician's perspective.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:23193846" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021